Case Commentary: Daptomycin Resistance in Staphylococcus argenteus-from Northern Australia to San Francisco.
Arnold S BayerSteven Y C TongPublished in: Antimicrobial agents and chemotherapy (2020)
Staphylococcus argenteus infection was initially described in Aboriginal patients in the Northern Territories of Australia as a predominant cause of skin infections and is rare outside Southeast Asia. A first well-characterized case of S. argenteus infection has now been described in the United States, involving a recurrent hemodialysis catheter infection, in which unstable daptomycin resistance evolved during daptomycin therapy. The unique colonial pigmentation of S. argenteus isolates in strains otherwise identified as Staphylococcus aureus is noteworthy.